Show simple item record

PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT

dc.contributor.authorFaivre-Finn, C.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorVillegas, A.
dc.contributor.authorDaniel, D.
dc.contributor.authorMurakami, S.
dc.contributor.authorHui, R.
dc.contributor.authorLee, K.
dc.contributor.authorCho, B. C.
dc.contributor.authorKubota, K.
dc.contributor.authorPoole, L.
dc.contributor.authorWadsworth, C.
dc.contributor.authorDennis, P.
dc.contributor.authorAntonia, S.
dc.contributor.authorVansteenkiste, J.
dc.contributor.authorNaidoo, J.
dc.date.accessioned2021-03-06T08:37:45Z
dc.date.available2021-03-06T08:37:45Z
dc.date.issued2018
dc.identifier.citationVansteenkiste J., Naidoo J., Faivre-Finn C., Ozguroglu M., Villegas A., Daniel D., Murakami S., Hui R., Lee K., Cho B. C. , et al., "PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT", JOURNAL OF THORACIC ONCOLOGY, cilt.13, 2018
dc.identifier.issn1556-0864
dc.identifier.othervv_1032021
dc.identifier.otherav_e1dabede-d3dc-408f-ba4f-d9643f012740
dc.identifier.urihttp://hdl.handle.net/20.500.12627/148692
dc.identifier.urihttps://doi.org/10.1016/j.jtho.2018.08.350
dc.language.isoeng
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSOLUNUM SİSTEMİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.titlePACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT
dc.typeMakale
dc.relation.journalJOURNAL OF THORACIC ONCOLOGY
dc.contributor.departmentKU Leuven , ,
dc.identifier.volume13
dc.identifier.issue10
dc.contributor.firstauthorID257549


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record